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Abstract Endometriosis is a gynecological disease charac-
terized by the presence of endometrial glandular epithelial and
stromal cells growing in the extra-uterine environment. The
disease afflicts 10%–15% of menstruating women causing
debilitating pain and infertility. Endometriosis appears to af-
fect every part of a woman’s reproductive system including
ovarian function, oocyte quality, embryo development and
implantation, uterine function and the endocrine system chor-
eographing the reproductive process and results in infertility
or spontaneous pregnancy loss. Current treatments are laden
with menopausal-like side effects and many cause cessation or
chemical alteration of the reproductive cycle, neither of which
is conducive to achieving a pregnancy. However, despite the
prevalence, physical and psychological tolls and health care
costs, a cure for endometriosis has not yet been found. We
hypothesize that endometriosis causes infertility via multifac-
eted mechanisms that are intricately interwoven thereby con-
tributing to our lack of understanding of this disease process.
Identifying and understanding the cellular and molecular
mechanisms responsible for endometriosis-associated infertil-
ity might help unravel the confounding multiplicities of infer-
tility and provide insights into novel therapeutic approaches
and potentially curative treatments for endometriosis.
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Endometriosis
Endometriosis is a gynecological disease characterized by
the presence of endometrial glandular and stromal cells
existing in the extra-uterine environment (Benagiano and
Brosens 1991). These extra-uterine glands and stroma,
called endometriotic lesions, can be found on the ovaries
and on the surfaces of pelvic cavity organs (Koger et al.
1993; Remorgida et al. 2007). Endometriosis, although not
malignant, occurs spontaneously in women and non-human
primates that menstruate, causing pain and infertility.
Because the disease requires expensive and invasive surgi-
cal procedures to diagnose, estimates of the prevalence of
endometriosis are difficult to establish. Estimates show that
endometriosis affects 10%–15% of all women of reproductive
age (Allaire 2006). These women often suffer for years before
the diagnosis of endometriosis is made (Hadfield et al. 1996).
A significant economic burden is imposed by endometri-
osis. Recent estimates of the costs of surgical removal of
endometriotic lesions are 17.3 billion dollars per year in the
USA alone (Simoens et al. 2007). Indirect costs such as the
loss ofwork productivity attributable to the debilitating chronic
pelvic pain accounts for an estimated 4.7 billion dollars lost in
the USA (Simoens et al. 2007). Without doubt, a more effec-
tive treatment for this disease needs to be developed.
Endometriosis (originally named adenomyoma) was de-
scribed 150 years ago by Rokitansky as the occurrence of
epithelial glands and stroma, resembling those found in the
mucosal lining of the uterus, growing elsewhere in the peri-
toneal cavity (Benagiano and Brosens 1991). The way that the
endometrium-like lesions became established outside of the
uterus was unclear but several hypotheses were proposed.
In 1940, the current widely accepted explanation for endo-
metriosis was put forward. Sampson posed a unique theory of
the pathogenesis of endometriosis called retrograde menstru-
ation. Retrograde menstruation occurs when naturally shed
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endometrium sloughs off but, instead of exiting though the
cervix, it moves out of the oviducts and into the peritoneal
cavity by retrograde movement. Up to 90% of all women are
estimated to experience some amount of retrograde menstru-
ation but only a portion of women develop endometriosis
(Ozkan et al. 2008; Seli et al. 2003). A combination of
retrograde menstruation, eutopic endometrial anomalies such
as the altered synthesis and secretion of proteins and gene
expression and abnormalities in the immune system might be
involved in the pathogenesis of endometriosis (Chegini et al.
2003; Fowler et al. 2007; Sharpe-Timms 2001; Siristatidis et
al. 2006; Ulukus et al. 2006; Wu and Ho 2003).
Other workers have hypothesized that an increase in telo-
merase production in the sloughed endometrium during retro-
grade menstruation has “enhanced replicative capacity” aiding
the establishment of ectopic lesions (Hapangama et al. 2008).
Additional hypotheses include: the induction theory in which,
during menstruation, the sloughing endometrium gives off
“factors” that cause changes in the surface epithelium of the
ovary leading to the differentiation of endometrium-like tissue
and migration to the peritoneal cavity; the in situ theory in
which totipotent cells remain undifferentiated from the fetus
surviving into adulthood and during the reproductive years,
becoming activated and thus differentiating into endometriotic
lesions (Nap et al. 2004). Endometrial stem cells might con-
tribute to the pathogenesis of endometriosis and explain some
rare and extreme cases of endometriosis (Sasson and Taylor
2008). Probably, a combination of mechanisms is involved
during the development of the disease.
The main symptoms of endometriosis are pain and infer-
tility (Allaire 2006; Berkley et al. 2005; Giudice and Kao
2004). The mechanisms of these symptoms in endometriosis
are not known. Not all patients experience the same symptoms
with endometriosis. Indeed, some women with endometriosis
do not learn about their disease until after elective sterilization
surgery. No cure is available for endometriosis and current
treatments focus on reducing the pain associated with the
disease often causing cessation or chemical alteration of the
reproductive cycle. Treatments are not curative and may cause
detrimental side effects. Further, many treatments are inappro-
priate for patients seeking treatment for infertility.
Infertility in women with endometriosis
Historically, endometriosis-associated infertility in women
has been associated with subtle, explicit, or multifaceted
abnormalities (Cahill and Hull 2000; Doody et al. 1988;
Garrido et al. 2002, 2003; Groll 1984; Hahn et al. 1986;
Hull et al. 1998; Tanbo et al. 1995; Tummon et al. 1988).
Indeed, endometriosis appears to affect every part of a
woman’s reproductive tract (Fig. 1). Many women with
minimal, mild, or moderate endometriosis experience
difficulties conceiving and maintaining pregnancy, neither
of which can be accounted for by anatomical obstructions
(Burns and Schenken 1999). It is estimated that 50% of
endometriosis patients are subfertile (Bulletti et al. 2010).
The following information characterizes reproductive irreg-
ularities associated with endometriosis.
Pituitary-ovarian feedback
In the normal cycle of fertile women, the pituitary secretes
follicle stimulated hormone (FSH) and luteinizing hormone
(LH) to stimulate growing ovarian follicles. These follicles
provide positive and negative feedback to the pituitary culmi-
nating in an LH surge to signal ovulation at the optimum time
(Senger 2005). However, in women with endometriosis, a
pituitary-ovarian axis dysfunction has been noted altering
feedback pathways thereby preventing normal cyclic changes
in the ovary. The length of the follicular phase is extended in
endometriosis (Cahill et al. 1995; Cheesman et al. 1982) when
compared with controls. Additionally, women with endome-
triosis seem to have abnormal patterns of LH secretion. The
LH surge is delayed in endometriosis with lower levels of LH
being present and occasionally biphasic surges occur leading
to abnormal urinary hormone profiles (Bancroft et al. 1992;
Cahill et al. 1995; Tummon et al. 1988; Williams et al. 1986).
These problems can impair follicular growth, ovulation and
corpus luteum development in the ovary specifically with
respect to the timing of ovarian events.
Impact on the ovary
Folliculogenesis
During the normal follicular phase, follicular growth is con-
trolled by a balance of hormones. When FSH causes follicles
to grow and develop, these follicles produce estradiol, activin
and inhibin, which, in turn, provide a feedback mechanism to
control the hypothalamus-pituitary-ovarian axis. While the
follicles are growing in size, the cells within the follicle are
changing. Visibly, an antrum forms and is filled with follicular
fluid.Within the follicle, follicular cells develop LH receptors,
which prepare the follicle for ovulation (Senger, 2005).
Folliculogenesis is impaired in women with endometriosis.
The number of preovulatory follicles, follicular growth, dom-
inant follicle size and follicular estradiol concentrations are
reduced in ovaries of endometriosis patients (Doody et al.
1988; Tummon et al. 1988; Cahill et al. 1995; Dlugi et al.
1989). The follicular fluid of patients with endometriosis have
been reported to have altered hormone profiles including
reduced estrogen, androgen and progesterone and increased
activin (Cahill and Hull 2000). Further, the follicular fluid
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from patients has been shown to contain factors such as
cytokines and growth factors that might promote the mainte-
nance of endometriotic lesions and lead to a suboptimum
follicular environment (Abae et al. 1994; Bahtiyar et al.
1998; Pellicer et al. 1998).
Ovulation
The process of ovulation is impaired in women with endo-
metriosis. During normal ovulation, the LH surge starts a
cascade of events in the follicle that leads to the expulsion of
the oocyte-cumulus complex. Several protective layers in-
cluding the granulosa, follicular basement membrane and
theca must be overcome within each ovulating follicle. To
achieve this, changes in proteolytic enzymes, cytokines,
inflammatory molecules, steroid hormones and vasculature
must occur (Espey 1980, 1994).
In women with endometriosis, mechanisms that facilitate
normal ovulation are impaired. As mentioned before, the
LH surge might be altered; however, others suggest that a
deficiency in follicular LH receptors (Ronnberg et al. 1984).
Additionally, lower levels of estrogen and progesterone
have been noted in the serum and urine of women with
endometriosis (Brosens et al. 1978; Cheesman et al. 1982;
Cunha-Filho et al. 2003; Smith et al. 2002; Trinder and
Cahill 2002; Tummon et al. 1988). Changes in proteolytic
enzymes (Ebisch et al. 2007; Smedts et al. 2006; Wunder et
al. 2005), cytokines (Carlberg et al. 2000; Garrido et al.
2000; Pellicer et al. 1998; Wunder et al. 2006), inflamma-
tory molecules (Carlberg et al. 2000; Lachapelle et al. 1996;
Wunder et al. 2006) and the vasculature (Abae et al. 1994;
Garrido et al. 2000; Pellicer et al. 1998), all of which are
required for normal ovulation, can also be found in the
follicles of women with endometriosis. Collectively, these
data provide evidence of mechanisms that could cause ovu-
latory dysfunction in endometriosis.
A phenomenon exists whereby oocytes become trapped in
a luteinizing corpus hemorrhagicum. This failure of ovulation,
defined as luteinized unruptured follicle syndrome (LUFs),
has been associated with endometriosis and infertility in wom-
en (Donnez and Thomas 1982; Kaya and Oral 1999; Marik
and Hulka 1978; Mio et al. 1992; Muse and Wilson 1982).
Peritoneal concentrations of steroid hormones, including pro-
gesterone and estradiol, are reported to decrease in women
with LUFs; however, whether this is a cause or consequence
of the phenomenon is unclear (Koninckx et al. 1980). Where-
as the mechanism causing this syndrome remains unknown,
any one of the factors necessary for follicular rupture could
contribute to failed ovulation.
Luteal function
After ovulation in normal cycles, the granulosa and theca
cells of the ovulated follicle differentiate into luteal cells.
Fig. 1 Factors associated with reduced fecundity in women with endometriosis
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The main function of this transformation is to produce
progesterone to prepare the reproductive tract for successful
implantation and pregnancy (Owen 1975). Altered luteal
function has been noted in endometriosis patients and
affects both large and small luteal cells (Cheesman et al.
1983; Cunha-Filho et al. 2003). Early luteal events, specif-
ically patterns of estrogen and progesterone secretion, are
altered in women with endometriosis (Cheesman et al.
1982). Indeed, endometriosis patients with luteal defects
secrete less progesterone than those from healthy patients
(Cunha-Filho et al. 2003). Women with endometriosis who
have a luteal deficiency are more likely to experience infer-
tility (Cunha-Filho et al. 2001).
Impact on oocyte quality
Women with endometriosis ovulate fewer oocytes than
healthy women (Al-Fadhli et al. 2006; Bergqvist and
D'Hooghe 2002; Cahill and Hull 2000; Kumbak et al. 2008;
Mahutte and Arici 2001; Yanushpolsky et al. 1998) and those
oocytes ovulated by women with endometriosis are some-
times compromised (Garrido et al. 2000, 2002, 2003; Navarro
et al. 2003; Pellicer et al. 2000). A recent study has shown that
women with endometriosis exhibit an increase in apoptosis of
the cumulus cells surrounding the oocyte (Díaz-Fontdevila et
al. 2009). Apoptosis in ovarian cells is a good indicator of
poor oocyte quality (Nakahara et al. 1997). Death of cumulus
cells probably leads to reduced oocyte quality and maturation
attributable to the loss of the essential support that the cumulus
cells give to the oocyte (e.g., pyruvate, hormones, growth
factors; Russell and Robker 2007).
Morphology is one indicator of the potential for each
oocyte to produce an embryo. Oocyte morphological charac-
teristics includes extracytoplasmic and cytoplasmic defects.
Extracytoplasmic defects that seem to impair fertilization rate
include abnormal first polar body extrusion and a large peri-
vitelline space (Rienzi et al. 2008). Cytoplasmic defects dis-
rupting fertilization rate include cytoplasmic granularity,
central location of cytoplasmic granularity and the presence
of vacuoles (Rienzi et al. 2008). Morphological analysis is,
however, a subjective evaluation and does not completely
correlate with the outcome.
The potential of the development of biomarkers clearly to
identify “good” versus “bad” oocytes is exciting. Potential
targets recently investigated include nuclear export factor
CRM1 in high-quality pig oocytes and components of the
ubiquitin-proteasome pathway in low-quality pig oocytes
(Powell et al. 2010). Despite this, current methods of visualiz-
ing these markers requires oocyte fixation rendering them
unusable for use in artificial reproductive techniques. Investi-
gators are trying to discover ways of using proteomic method-
ology to detect these biomarkers in oocyte maturationmedium.
Assisted reproductive therapies can help restore fertility in
women with endometriosis but unfortunately produce incon-
sistent results. Some studies have shown that the pregnancy
outcome with use of in vitro fertilization (IVF) is similar in
women with and without endometriosis (Bergendal et al.
1998; Geber et al. 1995; Huang et al. 1997). Women with
endometriosis undergoing IVF treatments involving oocytes
from a non-affected individual show normal implantation and
pregnancy rates (Simon et al. 1994). However, other workers
have reported that fertilization and/or embryo cleavage rates
after IVF, both in stimulated and unstimulated cycles, are
significantly lower in endometriosis compared with controls
(Cahill and Hull 2000; Harlow et al. 1996; Hull et al. 1998;
Tanbo et al. 1995). Fertilization and embryo cleavage rates
remain impaired in women with endometriosis after sperma-
tozoa from their partners are substituted with spermatozoa
from donors (Groll 1984; Hull et al. 1998). Additionally,
implantation rates of oocytes from donors with endometriosis
are reduced in recipients who do not have endometriosis
(Navarro et al. 2003).
Several factors from a woman with endometriosis contrib-
ute to the failure of a spermatozoon to fertilize a potentially
compromised oocyte. An increase in peritoneal macrophages
during endometriosis can lead to increased phagocytosis of
healthy spermatozoa that might have otherwise been able to
fertilize the ova (Muscato et al. 1983). Uterine/oviductal
sperm transport is impaired in endometriosis (Kissler et al.
2005, 2006, 2007; Leyendecker et al. 1996). This impairment
emerges in the early stages of endometriosis (Kissler et al.
2007). The peritoneal fluid of patients with endometriosis has
a negative impact on sperm binding to the zona pellucida of
the oocyte in vitro (Coddington et al. 1992). Peritoneal fluid of
women with endometriosis has been shown to increase DNA
fragmentation in sperm from healthy donors (Mansour et al.
2009b). Interleukin-6 (IL-6) and its soluble receptor, which
are present in the peritoneal fluid of women with endometri-
osis (Harada et al. 1997), reduce sperm motility (Iwabe et al.
2002; Yoshida et al. 2004). Additionally, endometriosis neg-
atively impacts sperm binding to the oviductal epithelium
(Reeve et al. 2005).
Impact on embryo development
Endometriosis negatively impacts embryo development
(Table 1). Because of the use of assisted reproductive tech-
niques, data are available about embryo quality and rates of
cleavage, implantation and pregnancy loss. Aberrant nuclear
and cytoplasmic events in embryos from women with endo-
metriosis are six times more likely compared with women
without endometriosis (Brizek et al. 1995). These events
include cytoplasmic fragmentation (Brizek et al. 1995), dark-
ened cytoplasm (Brizek et al. 1995), reduced cell numbers
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(Garrido et al. 2002; Pellicer et al. 1995; Tanbo et al. 1995)
and increased frequency of arrested embryos (Garrido et al.
2000; Yanushpolsky et al. 1998) leading to significantly fewer
transferable blastocysts (Garrido et al. 2002; Pellicer et al.
1995). Additionally, the quality of embryos that develop from
endometriosis patients has been shown to be reduced (Brizek
et al. 1995; Cahill and Hull 2000; Garrido et al. 2000, 2002;
Pellicer et al. 1995; Yanushpolsky et al. 1998). Treatment with
a gonadotrophin-releasing hormone agonist that temporarily
causes regression of the endometriotic lesions and cessation of
reproductive cyclicity helps to improve embryo quality in
these patients (Takahashi et al. 2004).
Inflammatory cytokines in the peritoneal fluid of women
with endometriosis provide a plausible hypothesis to explain
decreased embryo quality from such women. Exposure of the
embryo to peritoneal fluid while in the reproductive tract can
cause these defects (Esfandiari et al. 2005; Furukubo et al.
1998; Gomez-Torres et al. 2002). Murine embryos cultured in
the presence of peritoneal fluid from women with endometri-
osis have decreased rates of development after the two-cell
stage (Taketani et al. 1992). In a similar study, murine embryos
cultured in the presence of human peritoneal fluid from wom-
en with endometriosis show increased rates of DNA fragmen-
tation and apoptosis compared with treatment by control
peritoneal fluid (Mansour et al. 2009a). Further, embryos
cultured in the presence of IL-6 (found in the peritoneal fluid
of women with endometriosis) arrest at the blastocyst stage
or earlier (Iwabe et al. 2002). Even sera from women with
endometriosis are embryo toxic to murine embryos in vitro
(Abu-Musa et al. 1992; Ito et al. 1996; Tzeng et al. 1994).
Apoptosis or programmed cell death of the embryo can
occur through several mechanisms associated with endometri-
otic lesions such as increased concentrations of inflammatory
cytokines or reactive oxygen species (ROS; Agic et al. 2006;
Jana et al. 2010; Zeller et al. 1987; Fig. 2). Inflammatory
cytokines such as tumor necrosis factor-α can activate
caspase-dependent signaling pathways to increase apoptosis
(Hu 2003). ROS can cause mitochondrial damage and DNA
strand breaks (Lao et al. 2009). This might also encourage the
cell to undergo programmed cell death or apoptosis.
Table 1 Embryo defects in endometriosis (IVF in vitro fertilization, PF peritoneal fluid, GD gestational day, Pre-implant pre-implantation)
Experimental design Development Defect in endometriosis Citation
Women with endometriosis
IVF retrospective Zygote and
greater
Aberrant nuclear and cytoplasmic events Brizek et al. 1995
IVF retrospective 4-Cell Lower percentage of embryos reached
4-cell stage at 48 h
Yanushpolsky et al. 1998
IVF retrospective Pre-implant Reduced blastomere number. Increased
number embryos arrested
Pellicer et al. 1995
IVF retrospective Pre-implant Decreased blastomere cleavage rates Tanbo et al. 1995
IVF retrospective Pre-implant No difference in embryo quality Arici et al. 1996
Exposed murine embryos in vitro
to human sera
Pre-implant Embryo toxicity Abu-Musa et al. 1992;
Ito et al. 1996
Exposed 2-cell murine embryos in vitro
to human sera and PF
Pre-implant Increased embryo toxicity Tzeng et al. 1994
Exposed 2-cell murine embryos in vitro
to human PF
Pre-implant High embryo toxicity Gomez-Torres et al.
2002
Exposed murine embryos in vitro to human
PF
Pre-implant No effect on embryo development Dodds et al. 1992
Exposed 2-cell murine embryos in vitro
to human PF
Pre-morula blastocyst Decreased total cell number. Increased
arrested embryos
Esfandiari et al. 2005
Murine embryos incubated in human PF Pre-implant DNA fragmentation and increased
apoptosis
Mansour et al. 2009b
Murine embryos cultured in vitro with
human PF
Oocyte Decreased fertilization rates Ding et al. 2010
Pre-Implant Decreased development potential
Animal models of endometriosis
Rat model GD14 Decreased number of pups Vernon and Wilson 1985
Term
Rat model; PF treatment Pre-implant Decreased embryonic development rates Furukubo et al. 1998
Rat model 2-Cell Nuclear fragmentation Stilley et al. 2009
8-Cell Delayed or arrested cleavage
Rat model Zygote Improper distribution of microtubules Stilley et al. 2010
Increased cellular stress
Cell Tissue Res (2012) 349:849–862 853
ROS have been implicated as a potential source of
endometriosis-related infertility (Augoulea et al. 2009). Early
studies have shown increased concentrations of ROS and lipid
peroxides in the peritoneal fluid from women with endometri-
osis (Murphy et al. 1998; Zeller et al. 1987). More recent
studies have demonstrated no difference in the amount of
ROS in the peritoneal fluid (Agarwal et al. 2003) but a decrease
in the antioxidants present (Jackson et al. 2005). This suggests
that antioxidant protection is decreased in the peritoneal fluid
from women with endometriosis, an occurrence that could
negatively affect embryo development (Augoulea et al. 2009).
Impact on uterine receptivity
Uterine receptivity, which allows the developing embryo to
implant, is a complex process involving regulation by hor-
mones, cytokines, adhesion molecules and other factors
(Aghajanova et al. 2008). In women, uterine receptivity
can be marked by the expression of integrins, specifically
αVβ3 (Donaghay and Lessey 2007). Integrins are cell sur-
face receptors that mediate intracellular signals. Notably,
about 50% of women with endometriosis have decreased
or, in some cases, absent expression of endometrial αVβ3
(Donaghay and Lessey 2007). These data are correlated to
the ~50% of patients with endometriosis who, even with
assisted reproductive technologies, cannot conceive (Donaghay
and Lessey 2007; Lessey 2002).
HOXA10, which is known to be a potent stimulator of
αVβ3 expression, is a transcription factor and member of the
Homeobox family of genes expressed by the normal endo-
metrium (Eun Kwon and Taylor 2004). Decreased endome-
trial expression and altered methylation of HOXA10 have
been reported in women with endometriosis providing a
potential mechanism for the deficiency of αVβ3 (Donaghay
and Lessey 2007; Eun Kwon and Taylor 2004; Taylor et al.
1999; Vitiello et al. 2007). Other uterine biomarkers of
implantation such as glycodelin A, osteopontin, leukemia
inhibitory factor and lysophosphatidic acid receptor 3 are
reduced in women with endometriosis (Giudice et al. 2002;
Wei et al. 2009).
Together with a general decrease in the expression of
key uterine receptivity factors, steroid hormone pathways
are altered in endometriosis. Normally at the time of
implantation, estrogen receptors are downregulated; how-
ever, women with endometriosis have an upregulation of
endometrial estrogen receptors (Lessey et al. 1988). Aro-
matase is also aberrantly expressed by the endometrium
of women with endometriosis, increasing the amount of
active estradiol (Attar and Bulun 2006). To exacerbate
altered estrogen during receptivity even further, 17β-
hydroxysteroid dehydrogenase-2 is downregulated thereby
inhibiting estradiol inactivation leading to a local increase
in estrogen action (Giudice et al. 2002).
Conversely, progesterone actions, which are required for
endometrial receptivity, are reduced (Bulun et al. 2006). An
increase in progesterone compared with estrogen must occur
for successful endometrial receptivity to the implanting blas-
tocyst. Progesterone resistance has been reported in eutopic
and ectopic endometrium (Giudice and Kao 2004). Differen-
tial expression of the isoforms of the progesterone receptor
occurs in endometriosis: isoform A is present but B is not,
most likely because of aberrant methylation of its promoter
(Attia et al. 2000; Wu et al. 2006). Further, stromal cells of
endometriotic lesions do not express 17 β-hydroxysteriod
dehydrogenase type 2 thereby preventing the conversion of
estradiol2 to estradiol1, usually induced by progesterone
(Bulun et al. 2006). Reduced progesterone receptors and
decreased levels of estrone lead to high levels of estradiol
furthering the progesterone resistance. Collectively, these data
provide evidence for mechanisms involved in reduced uterine
receptivity.
Impact on embryo implantation
Quantifying embryo implantation in women with endo-
metriosis is difficult and has led to inconsistent results.
Fig. 2 Mechanisms by which endometriosis affects apoptosis signaling
in embryo development (TNF-α tumor necrosis factor-α)
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Women with endometriosis are reported to experience
implantation failure more often than controls (Arici et
al. 1996; Cahill and Hull 2000; Simon et al. 1994).
However, others disagree (Geber et al. 1995; Sung et
al. 1997). Much of the evidence regarding the success
or failure of implantation originates from IVF data.
Implantation rates are difficult to determine because of
the variation in patient procedures, including differences
in the numbers of embryos transferred and the selection
of the most ideal sperm, oocyte and embryo. Nonethe-
less, a significant decrease in implantation per embryo
transferred in IVF (Arici et al. 1996; Cahill and Hull
2000; Pellicer et al. 1995) has been found in association
with endometriosis.
Decreased rates of embryo implantation are an addi-
tional aspect of infertility in women with endometriosis
(Arici et al. 1996; Cahill and Hull 2000; Garrido et al.
2000; Yanushpolsky et al. 1998). Defects in embryo im-
plantation might be associated with hormone level alter-
ations, embryo anomalies and/or endometrial anomalies as
described. For example, embryo anomalies can include
slow growth and delayed blastocyst hatching, which are
detrimental for implantation of the embryo in the uterine
endometrium (Bazer et al. 2009).
Impact on the uterus: risk of miscarriage
Together with difficulty in establishing pregnancy, women
with endometriosis can have an increased risk of miscar-
riage and even recurrent miscarriage (Tomassetti et al. 2006;
Yanushpolsky et al. 1998). The mechanisms behind these
spontaneous pregnancy losses are unknown but are proba-
bly multifaceted including but not limited to, B cell immu-
nodeficiency and autoantibodies (Gleicher et al. 1989;
Mahutte and Arici 2001).
Investigators disagree about the increased risk of sponta-
neous pregnancy loss after implantation (Al-Azemi et al.
2000; Diaz et al. 2000; Matalliotakis et al. 2008a, 2008b;
Metzger et al. 1986; Olive et al. 1982; Pittaway et al. 1988;
Wheeler et al. 1983; Yanushpolsky et al. 1998). Some studies
suggest no increased risk of loss (Al-Azemi et al. 2000; Diaz
et al. 2000; Pittaway et al. 1988). However, many of these
investigations include women who have undergone IVF treat-
ment with stimulated cycles and selection of the most favor-
able embryos to be transferred, both of which could have
affected the outcome. Metzger et al. (1986) have however
noted that abortion rates drop to zero after surgical interven-
tion in women with endometriosis, suggesting that endome-
triosis itself does indeed play a role in these losses. Although
definitive proof that endometriosis causes spontaneous preg-
nancy loss is lacking, women with endometriosis have an
increased risk of spontaneous abortion.
Impact on peritoneal milieu
Endometriotic lesions secrete proteins and/or change the peri-
toneal environment in a way that has been hypothesized to
affect the establishment, maintenance and symptoms of endo-
metriosis. These substances include but are not limited to:
prostaglandins (Chishima et al. 2007; Drake et al. 1981;Moon
et al. 1983; Muzii et al. 1996; Sondheimer and Flickinger
1982); haptoglobin (Piva and Sharpe-Timms 1999;
Sharpe-Timms 2005; Sharpe-Timms et al. 1998, 2002); cyto-
kines such as IL-1, IL-6, IL-8 and IL-10; growth factors, such
as vascular endothelial growth factor, nerve growth factor,
transforming growth factor-β1 and 2, insulin-like growth
factor-2 (Anaf et al. 2002; Gazvani and Templeton 2002;
Sharpe-Timms 2001; Taylor et al. 2002); cellular remodeling
enzymes, such as the matrix metalloproteinases (MMPs) and
their inhibitors (tissue inhibitors of metalloproteinase, TIMPs;
Chung et al. 2001; Osteen et al. 1996, 2003; Sharpe-Timms et
al. 1995; Zhou and Nothnick 2005). Whereas the consequen-
ces of these and other molecules secreted from the lesions are
not fully known, the altered milieu in the peritoneal fluid can
clearly lead to changes in the reproductive tract.
Endometriosis is an heritable disease
Susceptibility to endometriosis is hypothesized to be herita-
ble based on the increased risk of developing endometriosis
if a family member is affected (Simpson et al. 2003). Ret-
rospective studies have shown that women with a first-
degree relative with endometriosis are 5%–8% more likely
to have endometriosis (Simpson et al. 2003). Having a sister
with endometriosis increases the risk of developing endo-
metriosis by 5.2-fold (Stefansson et al. 2002).
Genome-wide studies have identified several potential
loci that have mutations in women with endometriosis.
Treloar et al. (2005) have found, in a genome-wide linkage
study of over 1,000 sister-pair families, that women with
endometriosis have a possible susceptibility locus on chro-
mosome 10q26. This portion of the DNA includes coding
regions for several reproductively important genes including
EMX2, a gene required for reproductive tract development
and PTEN, a tumor suppressor gene (Treloar et al. 2005).
However, according to a review by Bischoff and Simpson
(2004), genetic mutations in this region, or any other loci
identified in population studies, of the DNA cannot alone
account for the heritability of endometriosis.
Endometriosis is an epigenetic disease
Because of the lack of evidence to substantiate the idea of a
common genetic mutation in endometriosis, the familial
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tendency of endometriosis might alternatively be attribut-
able to epigenetic reprogramming during embryonic or fetal
development (Dean et al. 2003). Epigenetics is a new excit-
ing field that affects many disciplines of science from fetal
origins of adult disease, assisted reproductive techniques,
cancer biology, to other diseases without a link to a specific
genetic anomaly (Dean et al. 2005). Epigenetics is the study
of alterations to the cytosine base pairs and histone modifi-
cations that affect gene expression but are not mutations of
the DNA itself.
In endometriosis, epigenetic changes might arise by sev-
eral mechanisms (Fig. 3). Endometriotic lesion secretory
products or inflammatory mediators from elevated numbers
of peritoneal macrophages and other immune cells present
in the peritoneal fluid might affect the methylation status of
the genome of the embryo or fetus (Hill et al. 1988). This
can occur by changing the gene expression of enzymes such
as DNA methyltransferases (DNMTs) and histone-
modifying enzymes such as histone deacetylases (Haaf
2006). One suggestion is that, in ectopic endometrium of
women with endometriosis, DNMT1, DNMT3A and
DNMT3B are over-expressed when compared with control
levels (Wu et al. 2007).
Inflammatory mediators might cause increased DNA
methylation by a secondary mechanism (Ushijima and
Okochi-Takada 2005). ROS associated with inflammation
cause DNA damage such as halogenated pyrimidines, which
mimic methylated cytosines (Lao et al. 2009; Valinluck and
Sowers 2007). These halogenated pyrimidines cause
DNMT1 to recognize the hemi-methylation of the DNA
leading to the methylation of the opposite strand of DNA
(Lao et al. 2009; Valinluck and Sowers 2007).
These aberrant methylation marks established during ga-
metogenesis or gestation might persist through childhood and
cause an increased risk for endometriosis. Aberrant epigenetic
programming in endometriosis might begin during several
events critical to the establishment of pregnancy such as
oocyte maturation (Nafee et al. 2008), pre-implantation em-
bryo development (Latham and Schultz 2001) and implanta-
tion (Paulson et al. 1990).
The methylation level of the oocyte genome remains low
until the oocyte is activated during folliculogenesis (Nafee
et al. 2008; Fig. 4). Upon follicular activation and recruit-
ment, methylation marks are established (Nafee et al. 2008).
No studies to date have focused on the effect of endometri-
osis on the establishment of methylation marks during oo-
cyte maturation and follicular development.
Shortly after fertilization the paternal genome of the
zygote in the mouse, rat and human undergoes active deme-
thylation (Fig. 4; Dean et al. 2003; Zaitseva et al. 2007). The
maternal zygotic genome undergoes a passive demethyla-
tion process from fertilization to the 8-cell stage in mice
(Dean et al. 2003). Incomplete erasure of methylation marks
can lead to increased incidence of disease later in life
(Junien et al. 2005).
During embryonic development most of the epigenetic
marks must be erased to allow for pluripotency. The grow-
ing embryo must make the transition from translating pro-
tein from maternally derived mRNA to transcribing its own
mRNA for translation (Latham and Schultz 2001). The
maternal to embryonic transition (MET) has been shown
to occur at the 2-cell stage in mice, the 4-cell stage in rats
Fig. 3 Potential mechanisms of aberrant DNA methylation in endo-
metriosis (DNMT DNA methyltransferase, HDAC histone deacetylase)
Fig. 4 Methylation dynamics during mammalian folliculogenesis and
early mammalian embryo development (blue paternal genome, red ma-
ternal genome) adapted from Reik W. et al., 2001
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and the 8-cell stage in human and bovine embryos (Telford et
al. 1990). Within about two cell divisions from theMET, most
maternal transcripts are degraded and the embryonic genome
is transcriptionally active (Zeng et al. 2004). The time period
immediately following this transition is ideal for studying the
impact of endometriosis on embryo gene expression and
epigenetic status, rather than maternal transcripts.
Another important part of embryo development is re-
methylation of the embryonic genome to allow for differenti-
ation of the cell lines (Fig. 4). By the blastocyst stage of
development, methylation marks return to the genome as the
blastomeres differentiate into various cell lineages including
the trophoblast and inner cell mass (Reik et al. 2001). During
this period of re-methylation, the embryo is hypothesized to
be highly sensitive to stressors such as temperature changes
and ROS exposure, which can cause aberrant methylation and
possibly lead to embryo death or embryo growth problems
such as those seen in endometriosis (Khosla et al. 2001).
Anomalous methylation during any part of embryo de-
velopment might cause an arrested cell cycle and apoptosis
of the blastomeres or inhibition of embryo implantation in
the endometrium (Feil 2009). Whereas this aberrant meth-
ylation might not directly affect subsequent cell cycles, it
might represent the embryonic origin of an adult disease
such as endometriosis, as methylation marks are not easily
removed once established (Nafee et al. 2008).
Human and rat embryo implantation is both an embryonic
and maternal process (Paulson et al. 1990). Once embryos
reach the blastocyst stage of development, they hatch from the
zona pellucida and implant in the uterine endometrium. The
maternal tissue must be correctly organized for implantation,
which necessitates the patterning of gene expression of genes
such as HOXA10 (Eun Kwon and Taylor 2004; Vitiello et al.
2007). For example, the suppression of HOXA10 by methyl-
ation might lead to failed implantation.
Evidence of epigenetic modifications in the eutopic en-
dometrium has been described in adults with endometriosis.
Genes important for implantation, such as HOXA10 and
progesterone receptor isoform B (PR-B), are differentially
methylated in the eutopic endometrium of women with
endometriosis compared with controls (Lee et al. 2009;
Wu et al. 2006). This aberrant methylation is correlated to
the differential expression of these genes seen in the eutopic
endometrium of women with endometriosis (Lee et al. 2009;
Wu et al. 2006).
Animal models of endometriosis
Because of the ethical limitations of working with human
embryos and experimentation in women, animal models of
endometriosis are frequently used to study the anomalies
associated with endometriosis (Sharpe-Timms 2002).
Common rodent models of endometriosis include the rat
(Vernon and Wilson 1985), rabbit (Schenken and Asch
1980) and mouse (Cummings and Metcalf 1995) models.
These models have many advantages such as decreased cost
and ethical limitations compared with working on primates
(D'Hooghe et al. 2009; Grummer 2006; Sharpe-Timms
2002). Endometriosis is induced in rodents by autologous
surgical transplantation of endometrial tissue from the ani-
mal’s own uterus into the arterial cascade of the small
intestine (Sharpe-Timms 2002). These implants mimic hu-
man endometriotic lesions in that they establish a blood
source, are influenced by the cycle stage and hormonal
levels and show signs of causing decreased fertility (Vernon
and Wilson 1985).
One advantage of the rat model is that the rat estrous
cycle lasts 4-5 days, compared with the typical 28-day
menstrual cycle in women, thereby allowing many studies
to be completed in a short period of time (Sharpe-Timms
2002). Moreover, reproductive cycle stage can easily be
monitored by using vaginal cytology (Sharpe-Timms 2002).
The rat model of endometriosis, because of its many sim-
ilarities to endometriosis in women, has been used to under-
stand mechanisms of subfertility (Table 1). Vernon and
Wilson validated the rat model of endometriosis in 1985. In
this model, the presence of endometrial implants in the peri-
toneum caused a decrease in fecundity by 28% at day 14 of
pregnancy and by 48% at term (Vernon and Wilson 1985).
Others have shown that the cytokine milieu of the peritoneal
fluid changes in rats with surgically induced endometriosis in
a similar fashion to that of humans (Umezawa et al. 2008). We
have demonstrated that the peritoneal fluid components can
enter the uterine horns via the oviduct and possibly affect
embryonic or eutopic-endometrial quality (Stilley et al. 2009).
Rats with endometriosis have also been shown to expe-
rience more spontaneous abortions and to have a decreased
litter size (Pal et al. 1999), an increased incidence of LUFS
(Moon et al. 1993) and increased early embryonic mortality
when compared with sham-operated controls (Stilley et al.
2009). This similarity to subfertility seen in human endo-
metriosis makes the rat model a suitable alternative for
studying the effects of endometriosis.
Based on the rat model, studies from our laboratory have
shown that TIMP1 is increased in the ovarian theca of antral
follicles, associated with decreased follicle numbers, LUFS
and poor embryo quality (Stilley et al. 2009). Further, re-
ducing levels of intraperitoneal fluid TIMP1 in Endo rats by
a TIMP1-function-blocking antibody mitigates the impact
of endometriosis on the ovary (Stilley et al. 2010). Con-
versely, increasing TIMP1 in rats by sham surgery decreases
ovarian function to levels similar to those of Endo rats with
fewer numbers of follicles and corpora lutea and poor em-
bryo quality (Stilley et al. 2010). In addition to these obser-
vations, work at our laboratory has shown that TIMP1 is
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able to act independently of MMP action to impair the
ovulatory function through changes to pathways involved
in extracellular matrix production, angiogenesis and apopto-
sis (Stilley and Sharpe-Timms 2011).
Interestingly, research at our laboratory has also demon-
strated that daughters of rats with endometriosis have similar
embryo anomalies as their mothers (Stilley et al. 2009). By
combining these findings suggesting an epigenetic inheritance
of endometriosis-like embryo anomalies in a rat model of
endometriosis (Stilley et al. 2009), the recent advances in the
field of epigenetics (Burdge and Lillycrop 2010) and the
development of possible treatments to prevent these aberrant
epigenetic marks during development (Waterland et al. 2008),
we are presently testing the hypothesis that endometriosis-
associated subfertility is multigeneration with an epigenetic
mode of inheritance in offspring from mothers with endome-
triosis. Epigenetic heritability of subfertility in endometriosis
is a unique idea that has not been previously postulated.
Concluding remarks
Endometriosis seems to impact, in a negative manner, every part
of the reproductive process subtly but significantly (Fig. 1).
However, to date, a cause and effect relationship between endo-
metriosis and reduced fecundity has not been established. Infer-
tility associated with endometriosis can be even more puzzling,
as not every patient experiences the same symptoms. Therefore,
not all patients respond to therapies in the same way, making
treatments particularly difficult to develop. Nonetheless, research
into therapeutic modalities for subfertility associated with endo-
metriosis needs to be continued, particularly with regard to
targeting the molecular mechanisms. Animal models have prov-
en to be valuable in providing insights into principles of mech-
anisms underlying subfertility in endometriosis, when such
studies in women are ethically restricted.
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